Medicaid Shortchanged on Epi-Pen Rebates. Attorney General Maura Healey announced on Oct. 3 that Mylan, the pharmaceutical company, will pay $20.3 million to the Massachusetts Medicaid program (MassHealth) to resolve allegations that it knowingly underpaid rebates owed to the program for EpiPens dispensed to program members/recipients. The payment is part of a “global settlement” with all of the 49 other states, the federal government, and the District of Columbia. “Mylan knowingly misrepresented this drug to MassHealth in order to underpay on rebates and make a profit at the expense of our state,” said Healey. “This settlement brings critical funds back to our MassHealth program. Companies that receive payments from taxpayer-funded programs must be held accountable when they abuse this system.” Massport Overcharged for Supplies. Interline Brands, a New Jersey company, will pay a settlement of nearly $2 million to resolve allegations it overcharged th...